 A PHASE IB DOSE ESCALATION STUDY OF THE COMBINATION OF LEE011 WITH LETROZOLE AND DOSE EXPANSION OF LEE011 WITH HORMONAL THERAPY FOR THE TREATMENT OF PRE-WITH GOSERELIN AND POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE, ADVANCED BREAST CANCER: 